U.S. cancer survival rates continue to improve
More Americans are living longer after a cancer diagnosis, according to the American Cancer Society’s annual report released Tuesday, Qazinform News Agency learnt from Anadolu Agency.
Five-year survival rates have risen to 70% for patients diagnosed between 2015 and 2021, compared with 63% in the mid‑1990s.
Gains are evident even in high‑mortality cancers, including myeloma, metastatic melanoma, liver cancer, metastatic rectal cancer, and advanced lung cancer.
Despite progress, lung cancer remains the deadliest form, causing more than twice as many deaths as any other cancer.
The report notes that the cancer mortality rate has steadily declined through 2023, preventing 4.8 million deaths since 1991. This improvement is largely attributed to reduced smoking, earlier detection, and advances in treatment.
Still, the burden remains heavy: in 2026 alone, projections indicate 2.1 million new cancer cases and 626,000 deaths across the United States.
Noteworthy, cancer death rates declined in Kazakhstan in past 5 years.
